1. Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma
   Andrea Gaißler et al, 2023, Journal for ImmunoTherapy of Cancer CrossRef
2. Latest evidence on clinical outcomes and prognostic factors of advanced urothelial carcinoma in the era of immune checkpoint inhibitors: a narrative review
   Satoru Taguchi et al, 2024, Japanese Journal of Clinical Oncology CrossRef